Levodopa/Carbidopa (Sinemet)

DRUG2 trials

Sponsors

NeuroDerm Ltd., University of South Florida

Conditions

Healthy Adult ParticipantsParkinson DiseaseParkinson's Disease

Phase 1

A Single Period Investigation to Assess the Tolerability of Healthy Subjects to Oral Sinemet® (Levodopa/Carbidopa)

CompletedNCT02486432

NeuroDerm Ltd.Parkinson's Disease

Start: 2015-04-30End: 2015-04-30Updated: 2015-07-01

Unknown Phase

Brain Dopamine Biomarker

Not yet recruitingNCT07748715

University of South FloridaHealthy Adult Participants, Parkinson Disease

Start: 2026-10-01End: 2027-09-30Target: 50Updated: 2026-08-12